argenx presents new data: argenx stock costs EUR 816.40 versus EUR 816.40 Xetra close
Published on 10/03/2026 at 12:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 29, 2026, argenx SE announced that it would present new data at the AANEM Annual Meeting and MGFA Scientific Session. In weekend trading at Lang & Schwarz on October 3, 2026, argenx stock costs EUR 816.40 at 11:58 a.m. CEST, unchanged at plus 0.00 percent versus the EUR 816.40 close at Lang & Schwarz on October 2, 2026.
Weekend trading at Lang & Schwarz
The EUR 816.40 price was unchanged from the EUR 816.40 close at Lang & Schwarz on October 2, 2026. The bid was EUR 816.00 and the ask was EUR 816.80 at 11:58 a.m. CEST. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of argenx stock.
New data across neuromuscular programs
According to the issuer announcement, the presentations covered clinical, long-term and real-world data for VYVGART and VYVGART Hytrulo in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. The release also described Phase 2 results for empasiprubart in multifocal motor neuropathy and Phase 1b results for adimanebart in congenital myasthenic syndromes.
The company said a real-world analysis of more than 1,100 US patients with myasthenia gravis showed a mean MG-ADL reduction of 4.7 points during the first three months for patients treated within one year of diagnosis, compared with 3.5 points for those treated more than three years after diagnosis.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026. The weekend-trading price and the October 2, 2026 close are both EUR 816.40 at the cited Lang & Schwarz time.
